Association between obesity and increase severity of COVID-19
Journal of Pharmaceutical Negative Results
; 13(3):249-254, 2022.
Article
in English
| EMBASE | ID: covidwho-2146651
ABSTRACT
Background:
The coronavirus disease 2019 (COVID-19) become pandemic in many countries. Many subsequent data shown that the obesity is a risk factor responsible for severity of COVID-19. Obese COVID-19 patient were significantly associated with elevation the inflammatory markers and coagulated factor. The sex has association with diseases severity specially obese COVID-19 patient, so more likely to become seriously ill,so those patients will hospitalized and admitted to ICU and more care requirement . Objective(s) The ambition of this study is to investigation whether obesity is implicated in exacerbation severity of COVID .19. Method(s) 381 COVID -19 patient was participated in this study,185 of them were non obese COVID-19 and the other 196 patient were Obese COVID-19, inflammatory and coagulation marker was measured. Result(s) The data show significant higher levels in interleukins IL-6, CRP, TNF-alpha, Ferritin, and D-dimer and failure to give significant level for IL-10 and glucose concentration among obese, and non-obese, obese based on BMI and depend on the sex . Conclusion(s) Obesity is significantly increase the severity of COVID-19 disease. The obese patient displays higher levels for inflammatory and coagulation factor specially in those patients has 35-39.9 BMI compared with normal weight individuals. The data indicated that the sex significantly interact with obesity on to COVID-19 severity enhancing. Copyright © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
Journal of Pharmaceutical Negative Results
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS